Medscape:2014年度美国内分泌科医生生活状态报告

2014-04-25 佚名 dxy

edscape网站陆陆续续刊登了25个专科医生的年度生活报告,中国的内分泌科医生想知道美国内分泌科医生过着什么样的生活吗? 哪些内分泌医生超重更严重呢? 2013年来自疾控中心的肥胖报告显示,男女总的肥胖流行率(35%)没有差别。 2013年盖洛普民意调查也支持这一结果。Medscape调查显示,13% 的男性内分泌医生和4%的女性内分泌医生的BMI ≥ 30 。 然而,保持健康的体重对于接受调查

Medscape网站陆陆续续刊登了25个专科医生的年度生活报告,中国的内分泌科医生想知道美国内分泌科医生过着什么样的生活吗?

哪些内分泌医生超重更严重呢?

2013年来自疾控中心的肥胖报告显示,男女总的肥胖流行率(35%)没有差别。 2013年盖洛普民意调查也支持这一结果。Medscape调查显示,13% 的男性内分泌医生和4%的女性内分泌医生的BMI ≥ 30 。

然而,保持健康的体重对于接受调查的医生们仍然是一个问题,与一般人群不同,内分泌医生超重者男性(28%)比女性(18%)要多。

内分泌医生选择什么样的饮食呢?

美国心脏协会/美国心脏病学心血管风险学会最新指南推荐地中海式饮食(富含水果,蔬菜,全谷类,鱼,橄榄油,瘦肉家禽,坚果,豆类)。

2013年关于健康饮食的盖洛普民意调查发现,60%的美国人每周吃5份水果和四份或四份以上的,其百分比与2012年医师在盖洛普民意测验报告单一样。

当Medscape调查的受访者被问及他们的饮食时,有63%的内分泌医生提及包含有日常量的水果和蔬菜的饮食。更糟的是,18%称,他们经常选择使用“meals on-the-go”(快餐食品,垃圾食品,从自动售货机餐)或典型的美国饮食(大部分时间食肉,碳水化合物大部分时间来自白米饭,土豆,或白面粉制品,高脂肪)。

虽然有32%的内分泌医生表示,他们介于超重与肥胖之间,只有12%的人在减肥或食用热量限制饮食。

内分泌医生多久在外面点餐一次呢?

梯形论坛关于外带食品的话题指出,美国分配给外带食品的预算百分比从190年的26.3%上升到2002年的46%。大众媒体随后的报道表明,此后这一比例并没有减少。

该论坛还认为,外出就餐更频繁与肥胖,较高的体内脂肪百分比,还有较高的BMI有关,其他研究也有相似的结果。

但是,目前尚不能确定是外出就餐与肥胖是否存在联系,或者那些在快餐连锁店就餐的人是否更易肥胖。在Medscape调查中,60%介于超重和肥胖之间的内分泌医生的说他们至少一个星期外出就餐一次。但 49%的正常和低体重者也是如此。

哪些内分泌医生使用膳食补充剂?

将近一半的美国人使用某种形式的膳食补充剂。年龄和性别会影响膳食补充剂的使用。在大于46岁并参加了Medscape调查的内分泌医生中,58%服用膳食补充剂,而45岁及以下的医生该比例为49%。

当考虑到性别差异时,61%的女性服用补充剂,而男性为49%。有趣的是,这些结果与最近的护士健康研究(NHS)的分析和卫生专业人员随访研究(HPFS)有差别,他们报导了更高的补充剂的使用率。

内分泌医生使用什么膳食补充剂呢?

约31%的内分泌医生服用多种维生素,比美国一般人群的调查使用率33%相近。15%内分泌医生服用omega - 3脂肪酸,40%服用维生素D,15%服用钙片。

尽管补充抗氧化剂的价值缺乏证据支持,12%内分泌医生服用维生素,5%服用辅酶Q10,以防止他汀类药物有关的肌痛。膳食补充剂在卫生专业人员中的使用率在1986年和2006年间有所增长,特别是在妇女服用维生素D( 2.2%至32.2%)和叶酸(0.8%至10.7%)方面。

鱼油的使用在男女性中都升高(女性为1.6%至18.1%,男性为3.3%至22.2%)。另一方面,抗氧化剂维生素A , β-胡萝卜素,维生素C和维生素E的使用稳步下降。

哪些医生会休假超过4星期呢?

最近的一份涉及了21个高收入国家的报告中显示,美国是唯一一个不给员工提供带薪休假的国家。美国人每年享受平均16个带薪休假日和节假日,这比其他富裕国家的公民少(例如,意大利,新西兰,比利时有30天;法国有31天西班牙和德国有34天)。

在所有医生当中,休假时间由于科室不同差别很大。麻醉医生和放射科医生有一半称他们每年享受超过4周的假期。内分泌医生垫底,只有11%的内分泌医生每年享受超过4周的假期。其次是家庭医生,内科和整形外科医生,只有13%享受这么长的假期。

内分泌医生做志愿者吗?

调查显示,约25%的男性女性内分泌医生,称自己从不做志愿者,这比Medscape2012年的调查数据(35%)有所降低。值得注意的是,2000年在《家庭医学档案》发表的一份调查显示,那些把慈善作为生活中指导原则的医生职业满足感更高。

内分泌医生在家里还是在工作中更快乐呢?

64%内分泌医生认为在家里很高兴,只有38%的内分泌医生认为在工作中会同样高兴。

哪些医生是最幸福的呢?

64%的内分泌医生认为,在家里非常高兴。只有38%的内分泌医生认为在工作中十分高兴。70%左右的皮肤科医生和眼科医生认为在家里很开心,而只有52%重症和传染病医师认为在家里很开心。

皮肤科医生也是在工作中最开心的医生,有53%自称在工作中非常高兴。在工作中最不快乐的是家庭医生和急诊医生,只有36%认为自己在工作中很开心。37%的内科医生和放射科医生认为自己在工作中很开心。

内分泌医生每周至少运动两次者所占百分比

2012年的盖洛普民意调查显示,54.7%的美国人,每周运动3次以上,而在同年医生的盖洛普民意测验中,58%的医生声称运动相同的次数。

当根据体重来查看运动频率时,当前Medscape调查中那些正常体重的的内分泌医生做得最好,其中74%的人每周至少锻炼两次。51%的超重者,40%的肥胖者声称,他们每周至少锻炼2次。
内分泌医生每周喝几次酒呢?

Medscape调查显示,内分泌医生并不嗜酒。男性和女性内分泌医生不喝酒的比例分别为27%和39%,而52%的女性和45%的男性称他们可能一周都不喝酒。这让人有些意外,因为适当饮酒对于心脏是有好处的。

哪些医生存款最多?

77%骨科医生声称自己有足够的储蓄,名列榜首,紧随其后的是眼科医生(76%)。内分泌医生为69%,排名为中上水平。只有57%的家庭医生和内科医生认为自己储蓄可观。多年来,初级保健医生和许多专家之间的收入差距一直是矛盾的焦点。《平价医疗法案》的部分修改就是为了解决这一问题,但这会起到多大的作用尚不清楚。

内分泌医生婚姻状态

在过去的几十年里,美国人初婚的年龄和持续时间有很大的改变。现在,人们初婚时年纪更大,与非配偶在一起时间更长。约一半的婚姻以离婚告终。据疾控中心统计,2000年至2011年间,结婚率下降了9%,而离婚率增加了7%。内分泌医生似乎在这方面做得很好。尽管女性内分泌医生(75%)相比,男性内分泌医生(83%) 更可能结婚或同居。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1897950, encodeId=c51d189e95088, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Mar 25 19:38:00 CST 2015, time=2015-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682175, encodeId=ed6a16821e58d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Mar 13 11:38:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725597, encodeId=0ce31e2559715, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Dec 31 08:38:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350949, encodeId=df5713509499c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458550, encodeId=3ace145855066, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606172, encodeId=f98016061e24e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=)]
    2015-03-25 smlt2008
  2. [GetPortalCommentsPageByObjectIdResponse(id=1897950, encodeId=c51d189e95088, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Mar 25 19:38:00 CST 2015, time=2015-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682175, encodeId=ed6a16821e58d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Mar 13 11:38:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725597, encodeId=0ce31e2559715, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Dec 31 08:38:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350949, encodeId=df5713509499c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458550, encodeId=3ace145855066, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606172, encodeId=f98016061e24e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=)]
    2015-03-13 gwc392
  3. [GetPortalCommentsPageByObjectIdResponse(id=1897950, encodeId=c51d189e95088, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Mar 25 19:38:00 CST 2015, time=2015-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682175, encodeId=ed6a16821e58d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Mar 13 11:38:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725597, encodeId=0ce31e2559715, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Dec 31 08:38:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350949, encodeId=df5713509499c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458550, encodeId=3ace145855066, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606172, encodeId=f98016061e24e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=)]
    2014-12-31 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1897950, encodeId=c51d189e95088, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Mar 25 19:38:00 CST 2015, time=2015-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682175, encodeId=ed6a16821e58d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Mar 13 11:38:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725597, encodeId=0ce31e2559715, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Dec 31 08:38:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350949, encodeId=df5713509499c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458550, encodeId=3ace145855066, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606172, encodeId=f98016061e24e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=)]
    2014-04-27 zhaojie88
  5. [GetPortalCommentsPageByObjectIdResponse(id=1897950, encodeId=c51d189e95088, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Mar 25 19:38:00 CST 2015, time=2015-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682175, encodeId=ed6a16821e58d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Mar 13 11:38:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725597, encodeId=0ce31e2559715, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Dec 31 08:38:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350949, encodeId=df5713509499c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458550, encodeId=3ace145855066, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606172, encodeId=f98016061e24e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1897950, encodeId=c51d189e95088, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Wed Mar 25 19:38:00 CST 2015, time=2015-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1682175, encodeId=ed6a16821e58d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31780, encryptionId=d4d031e8074, topicName=分泌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0da227938338, createdName=gwc392, createdTime=Fri Mar 13 11:38:00 CST 2015, time=2015-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725597, encodeId=0ce31e2559715, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Wed Dec 31 08:38:00 CST 2014, time=2014-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350949, encodeId=df5713509499c, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458550, encodeId=3ace145855066, content=<a href='/topic/show?id=6b5511492e2' target=_blank style='color:#2F92EE;'>#Medscape#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11492, encryptionId=6b5511492e2, topicName=Medscape)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e4ab6090887, createdName=bnjfx@128.com, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606172, encodeId=f98016061e24e, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Apr 27 06:38:00 CST 2014, time=2014-04-27, status=1, ipAttribution=)]

相关资讯

内外科协作治疗糖尿病的优势与互补

目前实施代谢手术的临床模式大多是由外科独立招募患者后进行手术治疗和术后随访,但存在缺乏术前对糖尿病系统评估、术式和手术具体参数的选择未体现个体化、术后随访注重早期而忽视中远期管理等问题。糖尿病涉及多种代谢紊乱,往往伴有多系统并发症,其本质为内科疾病,诊断与治疗的原则仍应遵循其特有规律。手术治疗只是其中一种治疗手段,糖尿病的综合控制需要多学科专业团队参与,对治疗流程进行科学整